| 【Company Research】I-Mab BioPharma (IMAB US) – CD73 confirmed as a promising target for cancer immunotherapy |
| 【Company Research】CG Services (6098 HK) – Acquisition of R&F Property Services: quick wrap up is the key |
| 【Sector Research】China Express Delivery Sector – Easing ASP pressure in Aug to drive sector rebound |
| 【Company Research】HUTCHMED (13 HK) – A home-grown, global-facing Biopharma |
| 【Company Research】Yum China (9987 HK) – Another hit taken, but stay mid-term positive |
| 【Sector Research】China Technology Sector – Apple Launch Event: iPhone 13/Watch 7 largely inline; no new AirPods 3 slightly disappointing |
| 【Company Research】AK Medical (1789 HK) – Big winner in National VBP |
| 【Sector Research】China Property Sector – NBS Aug data deteriorated rapidly |
| 【Company Research】CTGDF (601888 CH) – At near term trough; Shares likely mean-revert on sequentially better 4Q tourist traffic; Initiate at Buy |
| 【Company Research】United Energy Group (467 HK) – A fast-growing medium-sized IOC |